UMHAPT St. Ivan Rilski's University Hospital
Welcome,         Profile    Billing    Logout  
 1 Trial 
2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gruss, Hans-Jürgen
NCT06593743: The Safety and Dose Response to Single Anal Doses of NRL001

Completed
1
44
Europe
Perianal NRL001 Gel 3 strengths, methoxamine gel 0.3%, 1.0%, 3.0%, Intraanal NRL001 Gel 2 strengths, methoxamine gel 3.0%, 1.0%, Intrarectal NRL001 Gel, methoxamine gel 1.0%, NRL001: 10mg suppository, methoxamine suppository
Norgine
Faecal Incontinence
07/04
11/13
Krastev, Zahariy
GULLIVER-2, NCT05009680 / 2021-001235-12: A Single and Repeat Dose Trial in Participants With Hepatic Impairment

Active, not recruiting
1/2
54
Europe
GB1211, Placebo
Galecto Biotech AB, Comac Medical
Hepatic Impairment
07/22
07/23

Download Options